Skip to main content
. Author manuscript; available in PMC: 2021 Jun 10.
Published in final edited form as: Clin Immunol. 2019 Mar 26;202:49–58. doi: 10.1016/j.clim.2019.03.008

Fig. 6.

Fig. 6.

IL-2/IL-12/IL-18 promoted the production of IFN-γ in ILC1. PBMCs from healthy controls or SLE patients were treated with different stimuli for 3 days. Brelfeldin A was added in the last 6 h of the incubation period. Cells were collected and stained for flow cytometry. (A) Gating strategy is shown. MFI of IFN-γ gated on ILC1 and frequencies of IFN-γ positive ILC1 are presented: PBMCs from 5 healthy controls were stimulated with plasma from healthy controls or SLE patients (B, E); PBMCs from 11 healthy controls were stimulated with PBS or IL-2/IL-12/IL-18 (C, F); PBMCs from 11 SLE patients were stimulated with PBS or IL-2/IL-12/IL-18 (D, G). Each PBMC was divided into two parts and received different stimuli.